Literature DB >> 11403157

Ubiquitin and the molecular pathology of neurodegenerative diseases.

J Lowe1, J Mayer, M Landon, R Layfield.   

Abstract

Ubiquitin plays a central role in normal cellular function as well as in disease. It is possible to group ubiquitin-immunostained structures into several main groups, the most distinctive being the ubiquitin/intermediate filament/alphaB crystallin family of inclusions that seem to represent a general cellular response to abnormal proteins recently termed the aggresomal response. While ubiquitin immunohistochemistry is a very useful technique for detecting pathological changes and inclusion bodies in the nervous system this alone is not enough to classify inclusions, and a panel of antibodies is recommended to clarify any findings made by screening tissues with anti-ubiquitin. Several mechanistic possibilities now exist to explain the accumulation of ubiquitinated proteins in cells of the nervous system, understanding of which should lead to new therapeutic advances in the group of chronic neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403157     DOI: 10.1007/978-1-4615-1249-3_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein.

Authors:  S Murata; Y Minami; M Minami; T Chiba; K Tanaka
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

2.  Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.

Authors:  Kathryn M Donaldson; Wei Li; Keith A Ching; Serge Batalov; Chih-Cheng Tsai; Claudio A P Joazeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

3.  Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation.

Authors:  Benjamin B Gelman; Kimberly Schuenke
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

4.  Neuronal effects of 4-t-Butylcatechol: a model for catechol-containing antioxidants.

Authors:  Yi-Ching Lo; Yuxin Liu; Yi-Chin Lin; Yu-Tzu Shih; Chi-Ming Liu; Leo T Burka
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-14       Impact factor: 4.219

5.  Experimental and computational analysis of polyglutamine-mediated cytotoxicity.

Authors:  Matthew Y Tang; Carole J Proctor; John Woulfe; Douglas A Gray
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

6.  Deregulation of Neuro-Developmental Genes and Primary Cilium Cytoskeleton Anomalies in iPSC Retinal Sheets from Human Syndromic Ciliopathies.

Authors:  Andrea Barabino; Anthony Flamier; Roy Hanna; Elise Héon; Benjamin S Freedman; Gilbert Bernier
Journal:  Stem Cell Reports       Date:  2020-03-10       Impact factor: 7.765

7.  Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells.

Authors:  Anja-Kristina Brust; Holger K Ulbrich; Gail M Seigel; Norbert Pfeiffer; Franz H Grus
Journal:  Biomark Insights       Date:  2008-07-08

8.  Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition.

Authors:  Marianne S Poruchynsky; Dan L Sackett; Robert W Robey; Yvona Ward; Christina Annunziata; Tito Fojo
Journal:  Cell Cycle       Date:  2008-01-17       Impact factor: 5.173

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.